Advertisement
ICUI vs LMAT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICUI is a Buy and LMAT is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ICUI’s FA Score shows that 0 FA rating(s) are green whileLMAT’s FA Score has 2 green FA rating(s).
- ICUI’s FA Score: 0 green, 5 red.
- LMAT’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ICUI’s TA Score shows that 5 TA indicator(s) are bullish while LMAT’s TA Score has 5 bullish TA indicator(s).
- ICUI’s TA Score: 5 bullish, 4 bearish.
- LMAT’s TA Score: 5 bullish, 3 bearish.
Price Growth
ICUI (@Pharmaceuticals: Other) experienced а +3.72% price change this week, while LMAT (@Pharmaceuticals: Other) price change was +3.70% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.91%. For the same industry, the average monthly price growth was +6.19%, and the average quarterly price growth was -4.94%.
Reported Earning Dates
ICUI is expected to report earnings on Aug 10, 2026.
LMAT is expected to report earnings on Jul 23, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+3.91% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| ICUI | LMAT | ICUI / LMAT | |
| Capitalization | 3.71B | 2.26B | 164% |
| EBITDA | 299M | 96.3M | 310% |
| Gain YTD | 3.925 | 18.518 | 21% |
| P/E Ratio | 73.19 | 32.58 | 225% |
| Revenue | 2.16B | 256M | 843% |
| Total Cash | 288M | 367M | 78% |
| Total Debt | 1.33B | 190M | 698% |
ICUI | LMAT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 18 | 42 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 73 Overvalued | 17 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 31 | |
SMR RATING 1..100 | 90 | 53 | |
PRICE GROWTH RATING 1..100 | 46 | 52 | |
P/E GROWTH RATING 1..100 | 100 | 74 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LMAT's Valuation (17) in the Medical Specialties industry is somewhat better than the same rating for ICUI (73). This means that LMAT’s stock grew somewhat faster than ICUI’s over the last 12 months.
LMAT's Profit vs Risk Rating (31) in the Medical Specialties industry is significantly better than the same rating for ICUI (100). This means that LMAT’s stock grew significantly faster than ICUI’s over the last 12 months.
LMAT's SMR Rating (53) in the Medical Specialties industry is somewhat better than the same rating for ICUI (90). This means that LMAT’s stock grew somewhat faster than ICUI’s over the last 12 months.
ICUI's Price Growth Rating (46) in the Medical Specialties industry is in the same range as LMAT (52). This means that ICUI’s stock grew similarly to LMAT’s over the last 12 months.
LMAT's P/E Growth Rating (74) in the Medical Specialties industry is in the same range as ICUI (100). This means that LMAT’s stock grew similarly to ICUI’s over the last 12 months.
| ICUI | LMAT | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 54% | 1 day ago 75% |
| Stochastic ODDS (%) | 1 day ago 76% | 1 day ago 61% |
| Momentum ODDS (%) | 1 day ago 71% | 1 day ago 70% |
| MACD ODDS (%) | 1 day ago 58% | 1 day ago 74% |
| TrendWeek ODDS (%) | 1 day ago 67% | 1 day ago 70% |
| TrendMonth ODDS (%) | 1 day ago 71% | 1 day ago 67% |
| Advances ODDS (%) | 7 days ago 66% | 6 days ago 69% |
| Declines ODDS (%) | 9 days ago 72% | 17 days ago 53% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 77% |
| Aroon ODDS (%) | 1 day ago 69% | 1 day ago 62% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KRE | 76.18 | 1.33 | +1.78% |
| State Street® SPDR® S&PRgnllBkgETF | |||
| CPSY | 25.70 | 0.04 | +0.16% |
| Calamos S&P 500 Str Alt Prt ETF-Jan | |||
| UTWO | 47.99 | N/A | N/A |
| F/m US Treasury 2 Year Note ETF | |||
| BKEM | 92.15 | -2.32 | -2.45% |
| BNY Mellon Emerging Markets Equity ETF | |||
| AAUM | 19.75 | -1.34 | -6.35% |
| Tema Alternative Asset Managers ETF | |||
ICUI and
Correlation & Price change
A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with CLPT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then CLPT could also see price increases.
| Ticker / NAME | Correlation To ICUI | 1D Price Change % | ||
|---|---|---|---|---|
| ICUI | 100% | N/A | ||
| CLPT - ICUI | 57% Loosely correlated | N/A | ||
| A - ICUI | 50% Loosely correlated | +0.42% | ||
| MMSI - ICUI | 47% Loosely correlated | N/A | ||
| CERS - ICUI | 46% Loosely correlated | N/A | ||
| RVTY - ICUI | 46% Loosely correlated | +1.42% | ||
More | ||||
LMAT and
Correlation & Price change
A.I.dvisor indicates that over the last year, LMAT has been loosely correlated with ITGR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LMAT jumps, then ITGR could also see price increases.
| Ticker / NAME | Correlation To LMAT | 1D Price Change % | ||
|---|---|---|---|---|
| LMAT | 100% | N/A | ||
| ITGR - LMAT | 48% Loosely correlated | +1.20% | ||
| SYK - LMAT | 46% Loosely correlated | -0.46% | ||
| UFPT - LMAT | 44% Loosely correlated | N/A | ||
| AORT - LMAT | 40% Loosely correlated | +4.81% | ||
| RDNT - LMAT | 39% Loosely correlated | N/A | ||
More | ||||